JUBLPHARMA - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 19 Sept 25, 2:16 pm

Technical Rating: 3.7

Here’s a detailed technical analysis of Jubilant Pharmova Ltd. (JUBLPHARMA)

📊 Trend Overview

Current Trend: Reversing with mild bullish bias

Price is trading slightly above both 50-DMA (₹1,105) and 200-DMA (₹1,043), indicating a potential trend reversal.

RSI at 54.4 suggests neutral-to-bullish momentum.

MACD at 4.43 is positive, confirming early bullish crossover.

Volume is above average, supporting the recent upward move.

📈 Moving Averages

50-DMA: ₹1,105 — Immediate support.

200-DMA: ₹1,043 — Strong long-term support.

Price Action: Current price of ₹1,115 is above both DMAs — bullish setup forming.

📉 Momentum Indicators

RSI (14-day): 54.4 — Neutral zone, room for upside.

MACD: 4.43 — Bullish crossover, momentum building.

Volume: 1.52 lakh vs 1-week avg of 1.19 lakh — Uptick in volume, confirming interest.

📊 Bollinger Bands

Price likely near middle band — moderate volatility.

No squeeze or breakout pattern yet, but trend is strengthening.

📌 Support & Resistance Zones

Level Price (₹) Commentary

Support 1 1,105 50-DMA, short-term support

Support 2 1,043 200-DMA, long-term support

Resistance 1 1,160 Minor resistance zone

Resistance 2 1,310 52-week high, major resistance

🎯 Entry & Exit Zones

Optimal Entry: ₹1,100–₹1,115 — Near support with tight stop-loss.

Exit Zone: ₹1,160–₹1,300 — Resistance zone for profit booking.

🔍 Short-Term Signals

Momentum: Building — MACD bullish, RSI rising.

Breakout Potential: Moderate — Watch for volume surge above ₹1,160.

Bias: Bullish — Trend reversal underway, confirmation needed.

🧭 Summary

JUBLPHARMA is currently reversing from a prior downtrend, with improving technical indicators. Price action above key moving averages, rising RSI, and bullish MACD suggest a potential uptrend. Traders may consider entering near ₹1,100–₹1,115 and targeting ₹1,160–₹1,300 for exits. Monitor volume and RSI for breakout confirmation.

Would you like a comparison with other pharma stocks or alerts for breakout levels?

Edit in a page